Popular Articles

Early Combination Of Enbrel(R) (etanercept) And Methotrexate Halts Radiographic Progression In 90% Of Patients During Second Year Of The COMET Study
New data presented this week during the European League Against Rheumatism (EULAR) Annual Meeting in Copenhagen demonstrated that sustained combination therapy (etanercept and methotrexate) was consistently superior to continuous methotrexate monotherapy in providing clinical remission and radiographic non-progression over two years in patients with early active rheumatoid arthritis.1 These new data add to the body of evidence supporting the benefits of early intervention with a biologic treatment in patients with rheumatoid arthritis.
generic viagra online
Boston Scientific Welcomes Launch Of Syntax Score Website
Boston Scientific Corporation (NYSE: BSX) welcomed the launch of a new website, http://www.syntaxscore.com, dedicated to the understanding and use of the SYNTAX Score™, a novel angiographic tool used to measure the complexity of coronary artery disease. The Company made the announcement at the annual EuroPCR Scientific Program in Barcelona.
News of the day
Therapy Technique Cuts Divorce/Separation Rate By Nearly 50 Percent
Four simple questions on well-being asked at the start of each session of ongoing couples therapy can greatly increase chances for reconciliation and improved relationships, according to a newly published study. The largest clinical trial with couples to date, it shows that divorce and separation rates for couples that used this feedback technique were 46.2 percent less than that of couples who received therapy as usual. The findings, published in the August 3, 2009, Journal of Consulting and Clinical Psychology, are the results of a 2-year study conducted at the Vestfold Family Counseling Center in Norway by a U.S.-Norwegian team of researchers.
Health Insurance

Major Investment In Virology Research For Glasgow

The Medical Research Council is to invest ÷£28 million over five years in a partnership with the University of Glasgow to fund a new multidisciplinary centre of excellence in virology research. The University of Glasgow will contribute an additional ÷£10m. It is expected that the Centre will be located in a new building on the University"s Garscube Campus. This would enable researchers based there to share expertise, build upon existing collaborations and strengthen virus research capability in the UK overall. After a UK-wide call for bids to host the centre, applications from twelve universities were received. A panel of international virology experts judged that the Glasgow submission represented the strongest case and recommended it for support. The Council of the MRC made the funding decision at its May 2009 meeting. Research programmes at The Centre for Virus Research will tackle questions about viruses at all levels from the fine details of virus structure to the spread of viruses in human and animal populations. As viruses continually evolve, the centre will investigate new approaches to virus detection as well as the development of antiviral drugs and vaccines. While recent events have brought acute infectious diseases such as influenza to the fore, viruses are also important as causes of serious diseases such as liver failure or cancer following life-long chronic infection. To meet these challenges the Centre will gather and build expertise on many virus types and will provide a key re for advanced training of the next generation of scientists and clinicians in all aspects of virology. Professor James Neil, who led the joint University of Glasgow/MRC Virology Unit bid, said: "An important feature of the new centre will be the integration of human and animal virus research. Many of the emerging threats to human health come from viruses that can jump from animals to humans, and the strategy of combining expertise across these fields is timely."" "We welcome the opportunity to bring the expertise of the current MRC Virology Unit to the facility at Garscube and look forward to working together to ensure that the Glasgow centre is recognised as an international as well as a UK leader in this field" Professor Chris Preston, who led on behalf of the MRC Virology Unit in the joint bid, said: "This is an exciting development in a longstanding association between the MRC and the University of Glasgow."" "Within the centre, the Unit"s research programmes will derive great benefit from collaboration with University and NHS colleagues who specialise in complementary aspects of human and animal virology."" "A major theme of the Centre is the integration of basic, applied and clinical research to devise new treatments, an approach that aligns with MRC"s strategic aims for medical research in the UK." Welcoming the announcement, Principal of the University of Glasgow, Sir Muir Russell, said: "Virology research has long been a great strength at this University and the MRC"s decision is a resounding vote of confidence in the University of Glasgow."" "With this investment, virology will take its place alongside the existing world-class research themes at Glasgow University, namely cancer, cardiovascular disease and immunology. I welcome the Medical Research Council investment and look forward to the establishment of The Centre for Virus Research." Scottish Government Health Secretary, Nicola Sturgeon, said: "The new Centre for Virus Research will place Scotland at the cutting edge of critical international research and the work undertaken here will potentially benefit millions of people worldwide. It is well-deserved recognition of the world-class research already going on at the University and the MRC Virology Unit, and a substantial achievement for Scottish science."" "Among their wide-ranging investigations, experts here in Glasgow will study the Hepatitis C virus - work which will complement the Scottish Government"s ÷£43 million Hep C Action Plan. These researchers will also build close links with virologists working in our NHS, further cementing the links between clinical practice and research." Chief Executive of the Medical Research Council, Sir Leszek Borysiewicz, said: ""Medical Research Council support for The Centre for Virus Research is a strategic investment in interdisciplinary virology that will help to build capacity in virology research and train scientists to tackle the health problems posed by viruses now and in the future. It will build on a long history of MRC virology research in Glasgow and take this into a new, exciting, multidisciplinary partnership with Glasgow University."" Background information In June 2006 the MRC Research Programme Group began a strategic review of virology funding ahead of the forthcoming retirement of the MRC Virology Unit Director Professor Duncan McGeoch who will step down in September 2009. In June 2008 the MRC launched a call for proposals inviting applications for funding for a new multidisciplinary centre for virology research. Twelve submissions were received and three were shortlisted for full application. The proposal for a partnership between the University of Glasgow and the MRC Virology Unit was successful. Medical Research Council


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):